Literature DB >> 12065155

Inhibition of proliferation and induction of apoptosis by tetrandrine in HepG2 cells.

Su-Mi Yoo1, Seon-Hee Oh, Sang-Jun Lee, Bang-Wool Lee, Won-Gil Ko, Chang-Kiu Moon, Byung-Hoon Lee.   

Abstract

Tetrandrine is a bisbenzylisoquinoline alkaloid derived from the root of Stephania tetrandra S. Moore, which has been reported to elicit in vitro cytotoxic effects on HeLa cells, and in vivo suppressive effects on mouse ascites tumors. In the present study, we examined the antiproliferative and apoptosis-inducing activity of tetrandrine in HepG2 cells, a human hepatoma cell line. Tetrandrine showed potent cytotoxic activity in HepG2 cells (IC(50)=9.0+/-1.0 micro M) following incubation for 48 h. Dose-dependent induction of apoptosis was observed by agarose gel electrophoresis and flow cytometric analysis. Treatment of HepG2 cells with tetrandrine resulted in the activation of caspase-3 protease, and subsequent proteolytic cleavage of poly(ADP-ribose) polymerase. These results suggest that tetrandrine is potentially useful as a chemotherapeutic/chemopreventive agent in hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065155     DOI: 10.1016/s0378-8741(02)00082-x

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells.

Authors:  Ning Wang; Weidong Pan; Meifen Zhu; Maosheng Zhang; Xiaojian Hao; Guangyi Liang; Yibin Feng
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

2.  Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence.

Authors:  T Ohyama; K Sato; K Kishimoto; Y Yamazaki; N Horiguchi; T Ichikawa; S Kakizaki; H Takagi; T Izumi; M Mori
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

3.  Growth-Suppressive and Apoptosis-Inducing Effects of Tetrandrine in SW872 Human Malignant Liposarcoma Cells via Activation of Caspase-9, Down-Regulation of XIAP and STAT-3, and ER Stress.

Authors:  Mohammed Samsuzzaman; Byeong-Churl Jang
Journal:  Biomolecules       Date:  2022-06-17

4.  Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells.

Authors:  Tao Chen; Bing Ji; Yancui Chen
Journal:  J Nat Med       Date:  2013-04-06       Impact factor: 2.343

5.  Tetrandrine and thapsigargin release arachidonic acid from cells in culture and stimulate prostacyclin production in rat liver cells, but may do so by different pathways.

Authors:  Lawrence Levine
Journal:  BMC Pharmacol       Date:  2005-06-24

6.  Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells.

Authors:  Wei Liu; Bo Kou; Zhen-Kun Ma; Xiao-Shuang Tang; Chuan Lv; Min Ye; Jia-Qi Chen; Lei Li; Xin-Yang Wang; Da-Lin He
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

7.  Synthesis, biological evaluation and toxicity of novel tetrandrine analogues.

Authors:  Ramona Schütz; Martin Müller; Franz Geisslinger; Angelika Vollmar; Karin Bartel; Franz Bracher
Journal:  Eur J Med Chem       Date:  2020-09-04       Impact factor: 6.514

8.  Alkaloids isolated from natural herbs as the anticancer agents.

Authors:  Jin-Jian Lu; Jiao-Lin Bao; Xiu-Ping Chen; Min Huang; Yi-Tao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

Review 9.  Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy.

Authors:  Ting Liu; Xin Liu; Wenhua Li
Journal:  Oncotarget       Date:  2016-06-28

10.  Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinoma‑bearing mouse model.

Authors:  Wei-Chan Lin; Wei-Hsun Wang; Yi-Hsien Lin; Jyh-Der Leu; Shan-Yun Cheng; Yu-Jen Chen; Jeng-Jong Hwang
Journal:  Oncol Rep       Date:  2018-07-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.